IRF4 and plasma cell myeloma: In myeloma cells sourced from obese patients, ACSS2 is regulated by adipocyte‐secreted angiotensin II, where it stabilizes interferon regulatory factor 4 (IRF4) through acetylation, thereby upregulating IRF4‐controlled gene expression.67